Koers Grey Cloak Tech Inc OTC Bulletin Board
Aandelen
US3978451082
Farmaceutische producten
Omzet 2022 | 2,25 mln. 2,11 mln. | Omzet 2023 | 2,49 mln. 2,32 mln. | Marktkapitalisatie | 21,27 mln. 19,89 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | -2 mln. -1,87 mln. | EV/omzet 2022 | 6,37 x |
Nettoschuld 2022 | 528K 494K | Nettoschuld 2023 | 1,11 mln. 1,04 mln. | EV/omzet 2023 | 9 x |
K/w-verhouding 2022 |
-13,9
x | K/w-verhouding 2023 |
-8,49
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 26,43% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Duke Pitts
CEO | Chief Executive Officer | 64 | 28-09-18 |
William Bossung
FOU | Founder | 65 | 19-12-14 |
Robert Madden
DFI | Director of Finance/CFO | 52 | 01-03-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
William Bossung
FOU | Founder | 65 | 19-12-14 |
Duke Pitts
CEO | Chief Executive Officer | 64 | 28-09-18 |
Bill Croyle
BRD | Director/Board Member | 72 | 24-09-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,04% | 5,92 mld. | |
-15,13% | 4,51 mld. | |
-9,75% | 3,15 mld. | |
+2,14% | 3,1 mld. | |
-6,82% | 2,42 mld. | |
+47,87% | 1,97 mld. | |
-7,89% | 1,68 mld. | |
+0,09% | 1,65 mld. | |
-12,97% | 1,53 mld. |